Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5

Comparison 7.

Mifepristone (all doses) versus anordrin (all doses)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Observed number of pregnancies (all women) 7 1035 Risk Ratio (M‐H, Fixed, 95% CI) 0.26 [0.11, 0.63]
2 Any side effect 4 746 Risk Ratio (M‐H, Fixed, 95% CI) 0.62 [0.43, 0.91]
3 Specific side effects 2 Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
3.1 Spotting/bleeding after treatment 2 331 Risk Ratio (M‐H, Fixed, 95% CI) 1.82 [0.69, 4.77]
4 Menses 4 667 Risk Ratio (M‐H, Fixed, 95% CI) 1.14 [0.78, 1.68]
4.1 Delay 4 667 Risk Ratio (M‐H, Fixed, 95% CI) 1.14 [0.78, 1.68]